These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8319666)
21. Reactivity of aflatoxin B2a antibody with aflatoxin B1-modified DNA and related metabolites. Pestka JJ; Li YK; Chu FS Appl Environ Microbiol; 1982 Nov; 44(5):1159-65. PubMed ID: 6817711 [TBL] [Abstract][Full Text] [Related]
22. DNA adducts as exposure biomarkers and indicators of cancer risk. Poirier MC Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):907-12. PubMed ID: 9255579 [TBL] [Abstract][Full Text] [Related]
23. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan. Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313 [TBL] [Abstract][Full Text] [Related]
24. Quantitation of aflatoxin B1-DNA adducts in woodchuck hepatocytes and rat liver tissue by indirect immunofluorescence analysis. Zhang YJ; Chen CJ; Haghighi B; Yang GY; Hsieh LL; Wang LW; Santella RM Cancer Res; 1991 Mar; 51(6):1720-5. PubMed ID: 1900216 [TBL] [Abstract][Full Text] [Related]
25. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Egner PA; Wang JB; Zhu YR; Zhang BC; Wu Y; Zhang QN; Qian GS; Kuang SY; Gange SJ; Jacobson LP; Helzlsouer KJ; Bailey GS; Groopman JD; Kensler TW Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14601-6. PubMed ID: 11724948 [TBL] [Abstract][Full Text] [Related]
26. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts. Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702 [TBL] [Abstract][Full Text] [Related]
27. Excision of aflatoxin B1-imidazole ring opened guanine adducts from DNA by formamidopyrimidine-DNA glycosylase. Chetsanga CJ; Frenette GP Carcinogenesis; 1983 Aug; 4(8):997-1000. PubMed ID: 6409445 [TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity and mutagenicity of aflatoxin dichloride in normal and repair deficient diploid human fibroblasts. Mahoney EM; Ball JC; Swenson DH; Richmond D; Maher VM; McCormick JJ Chem Biol Interact; 1984 Jun; 50(1):59-76. PubMed ID: 6428759 [TBL] [Abstract][Full Text] [Related]
29. Aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissue. Zhang YJ; Chen CJ; Lee CS; Haghighi B; Yang GY; Wang LW; Feitelson M; Santella R Carcinogenesis; 1991 Dec; 12(12):2247-52. PubMed ID: 1721008 [TBL] [Abstract][Full Text] [Related]
30. Aflatoxin B1-adduct formation in rat and human small bowel enterocytes. Kolars JC; Benedict P; Schmiedlin-Ren P; Watkins PB Gastroenterology; 1994 Feb; 106(2):433-9. PubMed ID: 8299909 [TBL] [Abstract][Full Text] [Related]
31. Food restriction reduces aflatoxin B1 (AFB1)-DNA adduct formation, AFB1-glutathione conjugation, and DNA damage in AFB1-treated male F344 rats and B6C3F1 mice. Chou MW; Chen W J Nutr; 1997 Feb; 127(2):210-7. PubMed ID: 9039820 [TBL] [Abstract][Full Text] [Related]
32. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa. Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082 [TBL] [Abstract][Full Text] [Related]
33. Aflatoxin B1--DNA adduct formation in rat liver following exposure by aerosol inhalation. Zarba A; Hmieleski R; Hemenway DR; Jakab GJ; Groopman JD Carcinogenesis; 1992 Jun; 13(6):1031-3. PubMed ID: 1600607 [TBL] [Abstract][Full Text] [Related]
34. Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report. Lee HS; Sarosi I; Vyas GN Gastroenterology; 1989 Nov; 97(5):1281-7. PubMed ID: 2551766 [TBL] [Abstract][Full Text] [Related]
35. Aflatoxin exposure in Singapore: blood aflatoxin levels in normal subjects, hepatitis B virus carriers and primary hepatocellular carcinoma patients. Chao TC; Lo DS; Bloodworth BC; Gunasegaram R; Koh TH; Ng HS Med Sci Law; 1994 Oct; 34(4):289-98. PubMed ID: 7830511 [TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay. Haugen A; Groopman JD; Hsu IC; Goodrich GR; Wogan GN; Harris CC Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4124-7. PubMed ID: 6794029 [TBL] [Abstract][Full Text] [Related]
37. [Relationship between lung cancer and aflatoxin B1]. Georggiett OC; Muiño JC; Montrull H; Brizuela N; Avalos S; Gómez RM Rev Fac Cien Med Univ Nac Cordoba; 2000; 57(1):95-107. PubMed ID: 11188861 [TBL] [Abstract][Full Text] [Related]
38. Properties of aflatoxin-DNA adducts formed by photoactivation and characterization of the major photoadduct as aflatoxin-N7-guanine. Shaulsky G; Johnson RL; Shockcor JP; Taylor LC; Stark AA Carcinogenesis; 1990 Apr; 11(4):519-27. PubMed ID: 2108817 [TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and nontumorous liver tissue. Santella RM; Zhang YJ; Chen CJ; Hsieh LL; Lee CS; Haghighi B; Yang GY; Wang LW; Feitelson M Environ Health Perspect; 1993 Mar; 99():199-202. PubMed ID: 8391434 [TBL] [Abstract][Full Text] [Related]
40. Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies. Groopman JD; Haugen A; Goodrich GR; Wogan GN; Harris CC Cancer Res; 1982 Aug; 42(8):3120-4. PubMed ID: 6807538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]